 |
PDBsum entry 1b6u
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Killer cell inhibitory receptor
|
PDB id
|
|
|
|
1b6u
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
7:391-398
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I.
|
|
K.Maenaka,
T.Juji,
D.I.Stuart,
E.Y.Jones.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: T cells and natural killer (NK) cells perform complementary roles in
the cellular immune system. T cells identify infected cells directly through
recognition of antigenic peptides that are displayed at the target cell surface
by the classical major histocompatibility complex (MHC) class I molecules. NK
cells monitor the target cell surface for malfunction of this display system,
lysing potentially infected cells that might otherwise evade recognition by the
T cells. Human killer cell inhibitory receptors (KIRs) control this process by
either inhibiting or activating the cytotoxic activity of NK cells via specific
binding to MHC class I molecules on the target cell. RESULTS: We report the
crystal structure of the extracellular region of the human p58 KIR (KIR2DL3),
which is specific for the human MHC class I molecule HLA-Cw3 and related
alleles. The structure shows the predicted topology of two tandem
immunoglobulin-like domains, but comparison with the previously reported
structure of the related receptor KIR2DL1 reveals an unexpected change of 23
degrees in the relative orientation of these domains. CONCLUSIONS: The altered
orientation of the immunoglobulin-like domains maintains an unusually acute
interdomain elbow angle, which therefore appears to be a distinctive feature of
the KIRs. The putative MHC class I binding site is located on the outer surface
of the elbow, spanning both domains. The unexpected observation that this
binding site can be modulated by differences in the relative domain orientations
has implications for the general mechanism of KIR-MHC class I complex formation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 3.
Figure 3. Comparison of KIR2DL3 and KIR2DL1 structures. (a)
Comparison of the D1-D2 orientation in KIR2DL3 (red) and KIR2DL1
(green). Ca traces for superposition based on D2 are shown in
two orthogonal views. (b) Comparison of the D1-D2 interface in
KIR2DL3 (grey with sidechain atoms coloured orange, blue and red
for C, N and O, respectively) and KIR2DL1 (green). Key residue
sidechains are shown in ball-and-stick representation. The mauve
mesh depicts the sidechain electron density for residues 17,
100, 102, 178 and 188, for which the sidechain atoms beyond Ca
were omitted from the phasing model (2F[o]-F[c] map contoured at
1s).
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(1999,
7,
391-398)
copyright 1999.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.S.Campbell,
and
A.K.Purdy
(2011).
Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations.
|
| |
Immunology,
132,
315-325.
|
 |
|
|
|
|
 |
T.Graef,
A.K.Moesta,
P.J.Norman,
L.Abi-Rached,
L.Vago,
A.M.Older Aguilar,
M.Gleimer,
J.A.Hammond,
L.A.Guethlein,
D.A.Bushnell,
P.J.Robinson,
and
P.Parham
(2009).
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.
|
| |
J Exp Med,
206,
2557-2572.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Ahlenstiel,
M.P.Martin,
X.Gao,
M.Carrington,
and
B.Rehermann
(2008).
Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.
|
| |
J Clin Invest,
118,
1017-1026.
|
 |
|
|
|
|
 |
T.I.Arnon,
J.T.Kaiser,
A.P.West,
R.Olson,
R.Diskin,
B.C.Viertlboeck,
T.W.Göbel,
and
P.J.Bjorkman
(2008).
The crystal structure of CHIR-AB1: a primordial avian classical Fc receptor.
|
| |
J Mol Biol,
381,
1012-1024.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Hatherley,
K.Harlos,
D.C.Dunlop,
D.I.Stuart,
and
A.N.Barclay
(2007).
The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors.
|
| |
J Biol Chem,
282,
14567-14575.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.J.Norman,
L.Abi-Rached,
K.Gendzekhadze,
D.Korbel,
M.Gleimer,
D.Rowley,
D.Bruno,
C.V.Carrington,
D.Chandanayingyong,
Y.H.Chang,
C.Crespí,
G.Saruhan-Direskeneli,
P.A.Fraser,
K.Hameed,
G.Kamkamidze,
K.A.Koram,
Z.Layrisse,
N.Matamoros,
J.Milà,
M.H.Park,
R.M.Pitchappan,
D.D.Ramdath,
M.Y.Shiau,
H.A.Stephens,
S.Struik,
D.H.Verity,
R.W.Vaughan,
D.Tyan,
R.W.Davis,
E.M.Riley,
M.Ronaghi,
and
P.Parham
(2007).
Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.
|
| |
Nat Genet,
39,
1092-1099.
|
 |
|
|
|
|
 |
T.J.Mankelow,
N.Burton,
F.O.Stefansdottir,
F.A.Spring,
S.F.Parsons,
J.S.Pedersen,
C.L.Oliveira,
D.Lammie,
T.Wess,
N.Mohandas,
J.A.Chasis,
R.L.Brady,
and
D.J.Anstee
(2007).
The Laminin 511/521-binding site on the Lutheran blood group glycoprotein is located at the flexible junction of Ig domains 2 and 3.
|
| |
Blood,
110,
3398-3406.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.C.Jones,
S.E.Hiby,
A.Moffett,
J.Trowsdale,
and
N.T.Young
(2006).
Nature of allelic sequence polymorphism at the KIR3DL3 locus.
|
| |
Immunogenetics,
58,
614-627.
|
 |
|
|
|
|
 |
L.Deng,
and
R.A.Mariuzza
(2006).
Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.
|
| |
Semin Immunol,
18,
159-166.
|
 |
|
|
|
|
 |
M.Shiroishi,
M.Kajikawa,
K.Kuroki,
T.Ose,
D.Kohda,
and
K.Maenaka
(2006).
Crystal structure of the human monocyte-activating receptor, "Group 2" leukocyte Ig-like receptor A5 (LILRA5/LIR9/ILT11).
|
| |
J Biol Chem,
281,
19536-19544.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Biassoni,
and
N.Dimasi
(2005).
Human natural killer cell receptor functions and their implication in diseases.
|
| |
Expert Rev Clin Immunol,
1,
405-417.
|
 |
|
|
|
|
 |
C.E.Foster,
M.Colonna,
and
P.D.Sun
(2003).
Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors.
|
| |
J Biol Chem,
278,
46081-46086.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Radaev,
and
P.D.Sun
(2003).
Structure and function of natural killer cell surface receptors.
|
| |
Annu Rev Biophys Biomol Struct,
32,
93.
|
 |
|
|
|
|
 |
X.Saulquin,
L.N.Gastinel,
and
E.Vivier
(2003).
Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j).
|
| |
J Exp Med,
197,
933-938.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.G.Neves-Ferreira,
J.Perales,
J.W.Fox,
J.D.Shannon,
D.L.Makino,
R.C.Garratt,
and
G.B.Domont
(2002).
Structural and functional analyses of DM43, a snake venom metalloproteinase inhibitor from Didelphis marsupialis serum.
|
| |
J Biol Chem,
277,
13129-13137.
|
 |
|
|
|
|
 |
B.E.Willcox,
L.M.Thomas,
T.L.Chapman,
A.P.Heikema,
A.P.West,
and
P.J.Bjorkman
(2002).
Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.
|
| |
BMC Struct Biol,
2,
6.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Vilches,
and
P.Parham
(2002).
KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.
|
| |
Annu Rev Immunol,
20,
217-251.
|
 |
|
|
|
|
 |
K.Natarajan,
N.Dimasi,
J.Wang,
R.A.Mariuzza,
and
D.H.Margulies
(2002).
Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination.
|
| |
Annu Rev Immunol,
20,
853-885.
|
 |
|
|
|
|
 |
G.Jogl,
X.Tao,
Y.Xu,
and
L.Tong
(2001).
COMO: a program for combined molecular replacement.
|
| |
Acta Crystallogr D Biol Crystallogr,
57,
1127-1134.
|
 |
|
|
|
|
 |
R.Rajalingam,
C.M.Gardiner,
F.Canavez,
C.Vilches,
and
P.Parham
(2001).
Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.
|
| |
Tissue Antigens,
57,
22-31.
|
 |
|
|
|
|
 |
E.O.Long,
and
S.Rajagopalan
(2000).
HLA class I recognition by killer cell Ig-like receptors.
|
| |
Semin Immunol,
12,
101-108.
|
 |
|
|
|
|
 |
J.Wang,
and
E.L.Reinherz
(2000).
Structural basis of cell-cell interactions in the immune system.
|
| |
Curr Opin Struct Biol,
10,
656-661.
|
 |
|
|
|
|
 |
M.C.Deller,
and
E.Yvonne Jones
(2000).
Cell surface receptors.
|
| |
Curr Opin Struct Biol,
10,
213-219.
|
 |
|
|
|
|
 |
M.López-Botet,
M.Llano,
F.Navarro,
and
T.Bellón
(2000).
NK cell recognition of non-classical HLA class I molecules.
|
| |
Semin Immunol,
12,
109-119.
|
 |
|
|
|
|
 |
S.Ugolini,
and
E.Vivier
(2000).
Regulation of T cell function by NK cell receptors for classical MHC class I molecules.
|
| |
Curr Opin Immunol,
12,
295-300.
|
 |
|
|
|
|
 |
T.L.Chapman,
A.P.Heikema,
A.P.West,
and
P.J.Bjorkman
(2000).
Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2).
|
| |
Immunity,
13,
727-736.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.M.Davis,
I.Chiu,
M.Fassett,
G.B.Cohen,
O.Mandelboim,
and
J.L.Strominger
(1999).
The human natural killer cell immune synapse.
|
| |
Proc Natl Acad Sci U S A,
96,
15062-15067.
|
 |
|
|
|
|
 |
K.Maenaka,
and
E.Y.Jones
(1999).
MHC superfamily structure and the immune system.
|
| |
Curr Opin Struct Biol,
9,
745-753.
|
 |
|
|
|
|
 |
K.Maenaka,
T.Juji,
T.Nakayama,
J.R.Wyer,
G.F.Gao,
T.Maenaka,
N.R.Zaccai,
A.Kikuchi,
T.Yabe,
K.Tokunaga,
K.Tadokoro,
D.I.Stuart,
E.Y.Jones,
and
P.A.van der Merwe
(1999).
Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties.
|
| |
J Biol Chem,
274,
28329-28334.
|
 |
|
|
|
|
 |
K.Natarajan,
L.F.Boyd,
P.Schuck,
W.M.Yokoyama,
D.Eliat,
and
D.H.Margulies
(1999).
Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: identification of a site distinct from the TCR site.
|
| |
Immunity,
11,
591-601.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |